Constitutive and vitamin C-induced, NO-catalyzed release of heparan sulfate from recycling glypican-1 in late endosomes

Glycobiology

Volumn 16, Issue 12, 2006, Pages 1251-1261

  Mani, Katrin ^a   Cheng, Fang ^a   Fransson, Lars Åke ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

3BETA (2 DIETHYLAMINOETHOXY)ANDROST 5 EN 17 ONE; ANTIBODY; ASCORBIC ACID; CAVEOLIN 1; DEHYDROASCORBIC ACID; GLUCOSAMINE; GLYPICAN; HEPARAN SULFATE; MANNOSE; NITRIC OXIDE; RAB PROTEIN; RAB7 PROTEIN; SULFATE; SULFUR 35;

ACIDIFICATION; ANIMAL CELL; ARTICLE; BLADDER CARCINOMA; CANCER CELL CULTURE; CATALYSIS; CELL VACUOLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DEAMINATION; DEGRADATION; ENDOSOME; FIBROBLAST; HUMAN; HUMAN CELL; INTRACELLULAR SPACE; ISOTOPE LABELING; LYSOSOME; NEUROBLASTOMA CELL; NIEMANN PICK DISEASE; NONHUMAN; PRIORITY JOURNAL;

ANDROSTENES; ANIMALS; ASCORBIC ACID; BIOLOGICAL TRANSPORT; CATALYSIS; CELLS, CULTURED; ENDOSOMES; ENZYME INHIBITORS; FIBROBLASTS; GLYPICANS; HEPARITIN SULFATE; HUMANS; MICE; NITRIC OXIDE; RAB GTP-BINDING PROTEINS;

EID: 33751438848     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwl045     Document Type: Article

References (42)

1. Bame, K. (1993) Release of heparan sulfate glycosaminoglycans from proteoglycans in Chinese hamster ovary cells does not require proteolysis of the core protein. J. Biol. Chem., 268, 19956-19964.
2. Bellin, R., Capila, I., Lincecum, J., Park, P.W., Reizes, O., and Bernfield, M.B. (2003) Unlocking the secrets of syndecans: Transgenic organisms as a potential key. Glycoconj. J., 19, 295-304.
3. Campana, V., Sarnataro, D., and Zurzolo, C. (2005) The highways and byways of prion protein trafficking. Trends Cell Biol., 15, 102-111.
4. Cappai, R., Cheng, F., Ciccotosto, G.D., Needham, E.B., Masters, C.L., Multhaup, G., Fransson, L.-Å., and Mani, K. (2005) The amyloid precursor protein (APP) of Alzheimer disease and its paralog, APLP2, modulate the Cu/Zn-nitric oxide-catalyzed degradation of glypican-1 heparan sulfate in vivo. J. Biol. Chem., 280, 13913-13920.
5. Cheng, F., Lindqvist, J., Haigh, C.L., Brown, D.R., and Mani, K. (2006) Copper-dependent co-internalization of the prion protein and glypican-1. J. Neurochem., 98, 1445-1457.
6. Cheng, F., Mani, K., van den Born, J., Ding, K., Belting, M., and Fransson, L.-Å. (2002) Nitric oxide-dependent processing of heparan sulfate in recycling S-nitrosylated glypican-1 takes place in caveolin-1-containing endosomes. J. Biol. Chem., 277, 44431-44439.
7. Conner, S.D. and Schmid, S.L. (2003) Regulated portals of entry into the cell. Nature 422, 37-44.
8. +-dependent vitamin C transporter but not glucose transporter pathways. J. Biol. Chem., 280, 5211-5220.
9. Ding, K., Jönsson, M., Mani, K., Sandgren, S., Belting, M., and Fransson, L.-Å. (2001) N-unsubstituted glucosamine in heparan sulfate of recycling glypican-1 from suramin-treated and nitrite-deprived endothelial cells. Mapping of nitric oxide/nitrite-susceptible glucosamine residues to clustered sites near the core protein. J. Biol. Chem., 276, 3885-3894.
10. Ding, K., Mani, K., Cheng, F., Belting, M., and Fransson, L.-Å. (2002) Copper-dependent autocleavage of glypican-1 heparan sulfate by nitric oxide derived from intrinsic nitrosothiols. J. Biol. Chem., 277, 33353-33360.
11. Ding, K., Sandgren, S., Mani, K., Belting, M., and Fransson, L.-Å. (2001) Modulations of glypican-1 heparan sulfate structure by inhibition of endogenous polyamine synthesis. Mapping of spermine-binding sites and heparanase, heparin lyase and nitrix oxide/nitrite cleavage sites. J. Biol. Chem., 276, 46779-46791.
12. Edgren, G., Havsmark, B., Jönsson, M., and Fransson, L.-Å. (1997) Glypican (heparan sulfate proteoglycan) is palmitoylated, deglycanated and reglycanated during recycling in skin fibroblasts. Glycobiology, 7, 103-112.
13. Fedarko, N.S. and Conrad, H.E. (1986) A unique heparan sulfate in the nuclei of hepatocytes: Structural changes with the growth state of the cells. J. Cell Biol., 102, 587-599.
14. Fivaz, M., Vilbois, F., Thurnheer S., Pasquali, C., Abrami, L., Bickel. P.E., Parton, R.G., and van der Goot, F.G. (2002) Differential sorting and fate of endocytosed GPI-anchored proteins. EMBO J., 21, 3989-4000.
15. Fransson, L.-Å., Belting, M., Cheng, F., Jönsson, M., Mani, K., and Sandgren, S. (2004) Novel aspects of glypican glycobiology. CMLS Cell. Mol. Life Sci., 61, 1016-1024.
16. Fuller, M., Chau, A., Nowak, R.C., Hopwood, J.J., and Meikle, P.J. (2006) A defect in exodegradative pathways provides insight into endodegradation of heparan and dermatan sulfates. Glycobiology, 16, 318-325.
17. Horton, D. and Philips, K.D. (1973) The nitrous acid deamination of glycosides and acetates of 2-amino-2-deoxy-D-glucose. Carbohydr. Res., 30, 367-374.
18. Hurtado-Lorenzo, A., Skinner, El Annan, J., Futai, M., Sun-Wada, G.-H., Bourgoin, S., Casanova, J., Wildeman, A., Bechoua, S., Ausiello, D.A., Brown, D., and Marshansky, V. (2006) V-ATPase interacts with ARNO and Arf6 in early endosomes and regulates the protein degradative pathway. Nat. Cell Biol., 8, 124-136.
19. Ioannou, Y.A. (2005) Guilty until proven innocent: The case of NPC1 and cholesterol. Trends Biochem. Sci., 30, 498-506.
20. Ishihara, M., Fedarko, N.S., and Conrad, H.E. (1986) Transport of heparan sulfate into the nuclei of hepatocytes. J. Biol. Chem., 261, 13575-13580.
21. Liang, Y., Häring, M., Roughley, P.J., Margolis, R.K., and Margolis, R.U. (1997). Glypican and biglycan in the nuclei of neurons and glioma cells: Presence of functional nuclear localization signals and dynamic changes in glypican during the cell cycle. J. Cell Biol., 139, 851-864.
22. Liljeblad, M., Lundblad, A., Ohlson, S., and Påhlsson, P. (1998) Detection of low-molecular-weight heparin oligosaccharides (Fragmin®) using surface plasmon resonance. J. Mol. Recogn., 11, 191-193.
23. Mani, K., Belting, M., Ellervik, U., Falk, N., Svensson, G., Sandgren, S., Cheng, F., and Fransson, L.-Å. (2004) Tumor attenuation by 2(6-hydroxynaphthyl)-β-D-xylopyranoside requires priming of heparan sulfate and nuclear targeting of the products. Glycobiology, 14, 387-397.
24. Mani, K., Cheng, F., and Fransson, L.-Å. (2006) Defective NO-dependent, deaminative cleavage of glypican-1 heparan sulfate in Niemann-Pick C1 fibroblasts. Glycobiology, 16, 711-718.
25. Mani, K., Cheng, F., Havsmark, B., David, S., and Fransson, L.-Å. (2004) Involvement of glycosylphosphatidylinositol-linked ceruloplasmin in the copper/zinc-nitric oxide-dependent degradation of glypican-1 heparan sulfate in rat C6 glioma cells. J. Biol. Chem., 279, 12918-12923.
26. Mani, K., Cheng, F., Havsmark, B., Jönsson, M., Belting, M., and Fransson., L.-Å. (2003) Prion, amyloid β-derived Cu(II) ions, or free Zn(II) ions support S-nitroso-dependent autocleavage of glypican-1 heparan sulfate. J. Biol. Chem., 278, 38956-38965.
27. Mani, K., Jönsson, M., Edgren, G., Belting, M., and Fransson, L.-Å. (2000) A novel role for nitric oxide in the endogenous degradation of heparan sulfate during recycling of glypican-1. Glycobiology, 10, 577-586.
28. Nichols, B. (2003) Caveosomes and endocytosis of lipid rafts. J. Cell Sci. 116, 4707-4714.
29. Okada, Y., Yamada, S., Toyoshima, M., Dong, H., Nakajima, M., and Sugahara, K. (2002) Structural recognition by recombinant human heparanase that plays critical roles in tumor metastasis. Hierarchical sulfate groups with different effects and the essential target disulfated trisaccharide sequence. J. Biol. Chem., 277, 42488-42495.
30. Pejler, G., Lindahl, U., Larm, O., Scholander, E., Sandgren, E., and Lundblad, A. (1988) Monoclonal antibodies specific for oligosaccharides prepared by partial nitrous acid deamination of heparin. J. Biol. Chem., 263, 5197-5201.
31. Pelkmans, L. (2005) Secrets of caveolae- and lipid raft-mediated endocytosis revealed by mammalian viruses. Biochim. Biophys. Acta, 1746, 295-304.
32. Pfeffer, S.R. (2005) Structural clues to Rab GTPase functional diversity. J. Biol. Chem., 280, 15485-15488.
33. Pikas, D.S., Li, J.P., Vlodavsky, I., and Lindahl, U. (1998) Substrate specificity of heparanases from human hepatoma and platelets. J. Biol. Chem., 273, 18770-18777.
34. Rink, J., Ghigo, E., Kalaidzidis, Y., and Zerial, M. (2005) Rab conversion as a mechanism of progression from early to late endosomes. Cell, 122, 735-749.
35. Russell, M.R.G., Nickerson, D.P., and Odorizzi, G. (2006) Molecular mechanisms of late endosome morphology, identity and sorting. Curr. Opin. Cell Biol., 18, 422-428.
36. Vanier, M. and Millat, G. (2003) Niemann-Pick disease type C. Clin. Genet., 64, 269-281.
37. Vilar, R.E., Ghael, D., Li, M., Bhagat, D.D., Arrigo, L.M., Cowman, M.K., Dweck, H.S., and Rosenfeld, L. (1997) Nitric oxide degradation of heparin and heparan sulfate. Biochem. J., 324, 473-479.
38. Watanabe, N., Araki, W., Chui, D.-H., Makifuchi, T., Ihara, Y., and Tabira, T. (2004) Glypican-1 as an Aβ binding HSPG in the human brain: its localization in DIG domains and possible roles in the pathogenesis of Alzheimer's disease. FASEB J., 18, 1013-1015.
39. Westling, C. and Lindahl, U. (2002) Location of N-unsubstituted glucosamine residues in heparan sulfate. J. Biol. Chem., 277, 49247-49255.
40. Whitney, J.A., Gomez, M., Sheff, D., Kreis, T.E., and Mellman, I. (1995) Cytoplasmic coat proteins involved in endosome function. Cell, 83, 703-713.
41. Wilson. J.X. (2005) Regulation of vitamin C transport. Annu. Rev. Nutr., 25, 105-125.
42. Yogalingam, G. and Hopwood, J.J. (2001) Molecular genetics of mucopolysaccharidosis type IIIA and IIIB: Diagnostic, clinical and biological implications. Hum. Mutat., 18, 264-281.